nausea glp-1 Cumulative incidence of nausea/vomiting caused by glucagon‐like GLP-1 Nausea IV | Ozempic

They're everywhere

There are currently three approved DPP-4-resistant GLP-1RA therapies: exenatide, a GLP-1-like xenopeptide and two GLP-1RAs liraglutide, a human GLP-1 analogue, and the recently approved exendin-4-based agent lixisenatide

By week 12, the mean blood pressure decreased from baseline in the LY group compared to the placebo group

Writing in Nature , Petersen et al

Tirzepatide (sold as Zepbound and Mounjaro) is FDA approved, on Retatrutide vs Tirzepatide: How They Compare Retatrutide and tirzepatide are both once-weekly injections made by Eli Lilly, but they sit at very different points in their life cycle

Which Weight-Loss Medication Is Right for You